RankAlpha logo
Back to Rankings

NVCT

NuvectisF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NVCT vs peer average
24/100
NVCT vs. peer average (F vs. C)
Grade spread
B 3 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CABA is the first available peer comparator.

Clinical-stage small-cap biotech peer with similar financing and catalyst-driven volatility, though therapeutic focus is not oncology and therefore peer fit is only moderate.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCABACabaletta Bio
NVCT
Nuvectis
CABA
Cabaletta Bio
Grade
F
D
Momentum
96
64
Value
41
41
Sentiment
0
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CABA

NVCT / CABA
Grade Position
Below peers
NVCT vs. peer average (F vs. C)
24/100
Momentum
96
NVCT
Value
41
NVCT
Sentiment
0
CABA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NVCT
1
CABA
CABA
D
40/100
-1
2
PRQR
PRQR
F
20/100
Even
3
OVID
OVID
D
40/100
-1
4
SPRY
ARS Pharmaceuticals Inc Common
B
80/100
-3
5
CTKB
Cytek Biosciences Inc Common
C
60/100
-2
CABA is the first peer returned for this comparison set.